Cargando…

Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment

Postmenopausal osteoporosis (PMOP), as well as its associated increased risk for fragility fracture, is one of the most disabling consequences of aging in women. This present study aimed to identify candidate genes that involve pathogenesis of PMOP and the therapeutic mechanism of Liuweidihuang (LWD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Rui, Ren, Shan, Chen, Menghui, Wang, Yanli, Zhang, Guoliang, Shi, Lijuan, Zhang, Cuizhao, Su, Ruihong, Li, Yukun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369488/ https://www.ncbi.nlm.nih.gov/pubmed/30809532 http://dx.doi.org/10.1155/2019/1907906

Ejemplares similares

Corrigendum to “Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment”
por: Gong, Rui, et al.
Publicado: (2019)

Liuweidihuang Pill Alleviates Inflammation of the Testis via AMPK/SIRT1/NF-κB Pathway in Aging Rats
por: Wang, Yuxin, et al.
Publicado: (2020)

A comparison of gene expression profiles in patients with coronary artery disease, type 2 diabetes, and their coexisting conditions
por: Gong, Rui, et al.
Publicado: (2017)

Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology
por: Zhu, Fuping, et al.
Publicado: (2023)

Network pharmacology-based strategy to investigate pharmacological mechanism of Liuwei Dihuang Pill against postmenopausal osteoporosis
por: Wang, Qingchan, et al.
Publicado: (2022)

Exploring the Effect of Jiawei Buguzhi Pills on TGF-β-Smad Pathway in Postmenopausal Osteoporosis Based on Integrated Pharmacological Strategy
por: Yuan, Xiao, et al.
Publicado: (2021)

Bioinformatics analysis identification of AKT3 and RAC1 as key genes in postmenopausal osteoporosis
por: Zhang, Liyong, et al.
Publicado: (2022)

The Pharmacological Effects of Morroniside and Loganin Isolated from Liuweidihuang Wan, on MC3T3-E1 Cells
por: Li, Manyu, et al.
Publicado: (2010)

Molecular Subtype Classification of Postmenopausal Osteoporosis and Immune Infiltration Microenvironment Based on Bioinformatics Analysis of Osteoclast-Regulatory Genes
por: Gong, Yining, et al.
Publicado: (2023)

Investigation of candidate genes and mechanisms underlying postmenopausal osteoporosis using bioinformatics analysis
por: Zhu, Xiaozhong, et al.
Publicado: (2018)

The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia
por: Rettedal, Elizabeth A, et al.
Publicado: (2021)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
por: Huang, Xinzhou, et al.
Publicado: (2023)

A meta-analysis of VDR polymorphisms and postmenopausal osteoporosis
por: Fu, Lijuan, et al.
Publicado: (2020)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis
por: Cho, In-Jin, et al.
Publicado: (2015)

Liuwei Dihuang pill cures postmenopausal osteoporosis with kidney-Yin deficiency: Potential therapeutic targets identified based on gene expression profiling
por: Xu, Feng, et al.
Publicado: (2018)

Alterations in DNA methylation profiles in cancellous bone of postmenopausal women with osteoporosis
por: Zhou, Yu, et al.
Publicado: (2020)

Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis
por: Chen, Zhijie, et al.
Publicado: (2023)

Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
por: Wang, Xiqoqiang, et al.
Publicado: (2023)

The efficacy and safety of yukmijihwang-hwan (Liuweidihuang-wan) for type 2 diabetes mellitus without complications: A protocol for systematic review and meta-analysis
por: Baek, Jisoo, et al.
Publicado: (2022)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

Isoorientin ameliorates osteoporosis and oxidative stress in postmenopausal rats
por: Cao, Zhilin, et al.
Publicado: (2022)

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

Identifying a possible new target for diagnosis and treatment of postmenopausal osteoporosis through bioinformatics and clinical sample analysis
por: Liu, Ting, et al.
Publicado: (2021)

The prevalence and treatment rate trends of osteoporosis in postmenopausal women
por: Zhang, Xiaojuan, et al.
Publicado: (2023)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qtq6brke6hskf16rtca4pnlt4g